WallStreetZenWallStreetZen

NASDAQ: ARWR
Arrowhead Pharmaceuticals Inc Stock Ownership - Who owns Arrowhead Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Arrowhead Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James C. HamiltonChief Medical Officer2025-08-159,389$20.00
$187.78kSell
James C. HamiltonChief Medical Officer2025-08-13611$20.00
$12.22kSell
Christopher Richard AnzaloneChief Executive Officer2025-04-1150,800$11.49
$583.69kSell
Christopher Richard AnzaloneChief Executive Officer2025-04-1050,000$10.87
$543.50kSell
Christopher Richard AnzaloneChief Executive Officer2025-04-091,617$11.76
$19.02kSell
Christopher Richard AnzaloneChief Executive Officer2025-04-0935,305$9.93
$350.58kSell
Christopher Richard AnzaloneChief Executive Officer2025-04-093,400$10.75
$36.55kSell
Christopher Richard AnzaloneChief Executive Officer2025-03-1351,425$15.07
$774.97kSell
Christopher Richard AnzaloneChief Executive Officer2025-03-04133,333$7.75
$1.03MBuy
Christopher Richard AnzaloneChief Executive Officer2025-03-04133,333$17.02
$2.27MSell

1 of 5

ARWR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARWR insiders and whales buy or sell their stock.

ARWR Shareholders

What type of owners hold Arrowhead Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc14.07%19,424,887$402.29MInstitution
Vanguard Group Inc11.24%15,525,072$321.52MInstitution
Avoro Capital Advisors LLC7.68%10,600,000$219.53MInstitution
State Street Corp4.61%6,371,056$131.94MInstitution
David M. Knott4.06%5,609,690$116.18MInsider
Slate Path Capital LP3.79%5,232,000$108.35MInstitution
Fmr LLC3.74%5,170,310$107.08MInstitution
Christopher Richard Anzalone2.84%3,921,255$81.21MInsider
Geode Capital Management LLC2.16%2,978,505$61.68MInstitution
Ubs Am A Distinct Business Unit Of Ubs Asset Management Americas LLC1.94%2,684,317$55.59MInstitution

1 of 3

ARWR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARWR76.53%10.00%Net SellingNet Selling
VKTX67.70%8.98%Net SellingNet Selling
CRNX89.08%10.92%Net BuyingNet Selling
XENE97.09%2.91%Net BuyingNet Selling
RARE85.45%14.55%Net SellingNet Selling
View Top Biotech Stocks

Arrowhead Pharmaceuticals Stock Ownership FAQ

Who owns Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals (NASDAQ: ARWR) is owned by 76.53% institutional shareholders, 10.00% Arrowhead Pharmaceuticals insiders, and 13.47% retail investors. David M. Knott is the largest individual Arrowhead Pharmaceuticals shareholder, owning 5.61M shares representing 4.06% of the company. David M. Knott's Arrowhead Pharmaceuticals shares are currently valued at $118.81M.

If you're new to stock investing, here's how to buy Arrowhead Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.